Literature DB >> 32295909

Varicella-Zoster Virus (VZV) Small Noncoding RNAs Antisense to the VZV Latency-Encoded Transcript VLT Enhance Viral Replication.

Punam Bisht1, Biswajit Das1, Paul R Kinchington2, Ronald S Goldstein3.   

Abstract

Small noncoding RNAs (sncRNA), including microRNA (miR), are expressed by many viruses to provide an additional layer of gene expression regulation. Our work has shown that varicella-zoster virus (VZV; also called human herpesvirus 3 [HHV3]), the human alphaherpesvirus causing varicella and herpes zoster, expresses 24 virally encoded sncRNA (VZVsncRNA) in infected cells. Here, we demonstrate that several VZVsncRNA can modulate VZV growth, including four VZVsncRNA (VZVsncRNA10, -11, -12, and -13) that are antisense to VLT, a transcript made in lytic infections and associated with VZV latency. The influence on productive VZV growth and spread was assessed in epithelial cells transfected with locked nucleotide analog antagonists (LNAA). LNAA to the four VZVsncRNA antisense to VLT significantly reduced viral spread and progeny titers of infectious virus, suggesting that these sncRNA promoted lytic infection. The LNAA to VZVsncRNA12, encoded in the leader to ORF61, also significantly increased the levels of VLT transcripts. Conversely, overexpression of VZVsncRNA13 using adeno-associated virus consistently increased VZV spread and progeny titers. These results suggest that sncRNA antisense to VZV may regulate VZV growth, possibly by affecting VLT expression. Transfection of LNAA to VZVsncRNA14 and VZVsncRNA9 decreased and increased VZV growth, respectively, while LNAA to three other VZVsncRNA had no significant effects on replication. These data strongly support the conclusion that VZV replication is modulated by multiple virally encoded sncRNA, revealing an additional layer of complexity of VZV regulation of lytic infections. This may inform the development of novel anti-sncRNA-based therapies for treatment of VZV diseases.IMPORTANCE Varicella-zoster virus (VZV) causes herpes zoster, a major health issue in the aging and immunocompromised populations. Small noncoding RNAs (sncRNA) are recognized as important actors in modulating gene expression. This study extends our previous work and shows that four VZVsncRNA clustering in and near ORF61 and antisense to the latency-associated transcript of VZV can positively influence productive VZV infection. The ability of multiple exogenous small oligonucleotides targeting VZVsncRNA to inhibit VZV replication strengthens the possibility that they may inform development of novel treatments for painful herpes zoster.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  herpes zoster; noncoding RNA; varicella-zoster virus

Mesh:

Substances:

Year:  2020        PMID: 32295909      PMCID: PMC7307171          DOI: 10.1128/JVI.00123-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.

Authors:  B Karsten Tischer; Jens von Einem; Benedikt Kaufer; Nikolaus Osterrieder
Journal:  Biotechniques       Date:  2006-02       Impact factor: 1.993

2.  Bioinformatically-predicted varicella zoster virus small non-coding RNAs are expressed in lytically-infected epithelial cells and neurons.

Authors:  Linoy Golani-Zaidie; Tatiana Borodianskiy-Shteinberg; Punam Bisht; Biswajit Das; Paul R Kinchington; Ronald S Goldstein
Journal:  Virus Res       Date:  2019-10-12       Impact factor: 3.303

3.  A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.

Authors:  Xianzhi Jiang; Don Brown; Nelson Osorio; Chinhui Hsiang; Lily Li; Lucas Chan; Lbachir BenMohamed; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-02-03       Impact factor: 2.643

4.  Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.

Authors:  Kening Wang; Tsz Y Lau; Melissa Morales; Erik K Mont; Stephen E Straus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.

Authors:  Randall J Cohrs; Donald H Gilden
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

6.  Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.

Authors:  Dongli Pan; Jean M Pesola; Gang Li; Seamus McCarron; Donald M Coen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 7.  Are miRNAs critical determinants in herpes simplex virus pathogenesis?

Authors:  Siddheshvar Bhela; Barry T Rouse
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

8.  Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture.

Authors:  Omar Flores; Sanae Nakayama; Adam W Whisnant; Hassan Javanbakht; Bryan R Cullen; David C Bloom
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

9.  Pseudorabies virus infected porcine epithelial cell line generates a diverse set of host microRNAs and a special cluster of viral microRNAs.

Authors:  Yi-Quan Wu; Di-Jun Chen; Hua-Bin He; Dong-Sheng Chen; Ling-Ling Chen; Huan-Chun Chen; Zheng-Fei Liu
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 10.  The Role of microRNAs in the Pathogenesis of Herpesvirus Infection.

Authors:  Diogo Piedade; José Miguel Azevedo-Pereira
Journal:  Viruses       Date:  2016-06-02       Impact factor: 5.048

View more
  5 in total

Review 1.  Fraternal Twins: The Enigmatic Role of the Immune System in Alphaherpesvirus Pathogenesis and Latency and Its Impacts on Vaccine Efficacy.

Authors:  Barry T Rouse; D Scott Schmid
Journal:  Viruses       Date:  2022-04-21       Impact factor: 5.818

2.  Variable Gene Expression in Human Ganglia Latently Infected with Varicella-Zoster Virus.

Authors:  Peter G E Kennedy; Paul Montague
Journal:  Viruses       Date:  2022-06-09       Impact factor: 5.818

3.  Studies of Infection and Experimental Reactivation by Recombinant VZV with Mutations in Virally-Encoded Small Non-Coding RNA.

Authors:  Punam Bisht; Biswajit Das; Tatiana Borodianskiy-Shteinberg; Paul R Kinchington; Ronald S Goldstein
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

Review 4.  Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1.

Authors:  Juliette Savoret; Jean-Michel Mesnard; Antoine Gross; Nathalie Chazal
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

5.  Locked-nucleotide antagonists to varicella zoster virus small non-coding RNA block viral growth and have potential as an anti-viral therapy.

Authors:  Biswajit Das; Punam Bisht; Paul R Kinchington; Ronald S Goldstein
Journal:  Antiviral Res       Date:  2021-07-22       Impact factor: 10.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.